Pietro Bersani's most recent trade in Kiromic BioPharma Inc was a trade of 2,500 Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on Aug. 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiromic BioPharma Inc | Pietro Bersani | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 23 Aug 2024 | 2,500 | 141,345 | - | 2.2 | 5,500 | Common Stock |
| Kiromic BioPharma Inc | Pietro Bersani | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 23 Aug 2024 | 988 | 142,333 | - | 1.9 | 1,907 | Common Stock |
| Kiromic BioPharma Inc | Pietro Bersani | Director, CEO | Purchase of securities on an exchange or from another person at price $ 3.28 per share. | 11 Jun 2024 | 3,000 | 138,845 | - | 3.3 | 9,840 | Common Stock |
| Kiromic BioPharma Inc | Pietro Bersani | Director, CEO | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 11 Jun 2024 | 3,000 | 135,845 | - | 3.2 | 9,690 | Common Stock |
| Kiromic BioPharma Inc | Pietro Bersani | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 45,968 | 45,968 | - | 0 | Restricted Stock Award | |
| Kiromic BioPharma Inc | Pietro Bersani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 638,298 | 638,298 | - | 0 | Common Stock |